Written by: Jeremiah Moore, PharmD
Download Here

Selinexor (Xpovio®) is a novel medication for patients with relapsed, refractory multiple myeloma. This PQI will provide background on the novel mechanism of action and discuss effective practices to maximize the use of selinexor therapy.

Continue reading Selinexor Patient Management

Read More